Best Aplastic anemia doctors in Israel: TOP 18 doctors

Doctor information is currently being updated. Dr. Ron practices at Sourasky Medical Center (Ichilov).

Dr. Ram has performed several hundred stem cell transplants – a key treatment for aplastic anemia – at Sourasky Medical Center.

• Board-certified in both Hematology and Medical Oncology
• Fellowship-trained at Westchester Medical Center in New York
• Authored over 30 scientific articles and a textbook chapter
• Extensive experience in complex bone marrow disorders

300+ bone marrow and umbilical blood transplantations – Dr. El Hasid leads pediatric oncohematology at Dana Dwek Children's Hospital.

• Head of Pediatric Oncohematology and Oncology Department
• Member of American Association for Hematology
• Published 50 research papers in the field
• Trained at City of Hope Hospital in Los Angeles

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

900+ bone marrow transplants performed – Dr. Michael Shapira is a leading hematologist at Sourasky Medical Center.

• Specialized in bone marrow transplantation at Hadassah Medical Center
• Recognized for advancing transplantation medicine
• Speaks English and Hebrew fluently
• Graduated from Hebrew University medical school

Director of children's hematology oncology at Sourasky Medical Center – Dr. Levin specializes in blood disorders and pediatric bone cancer.

• Coordinates sarcoma treatment with the Oncology-orthopedic department
• Expert in hematology for premature infants
• Trained at Rizzoli Orthopaedic Institute in Italy
• Member of ISPHO – Israel's pediatric hemato-oncology association

Dr. Kirshner is involved in cutting-edge research and clinical trials for aplastic anemia, including phase III trials at Sourasky Medical Center.

• Fellowship-trained in hematology at Montefiore Medical Center
• Specializes in rare blood disorders like aplastic anemia
• Over 32 years of experience of experience in hematology and oncology
• Research focuses on innovative treatment protocols
• Fellow of the American Society of Hematology

Head of the Hematology and Bone Marrow Transplantation Institute at Sourasky Medical Center – Dr. Aviv brings leadership and deep expertise in aplastic anemia.

• 34 years of experience specializing in hematology and oncology
• Board-certified with multiple professional society memberships
• Focuses on myelodysplastic syndromes and transplants

Dr. Herishanu Yair has received multiple awards for his contributions to hematology, including the Young Investigator Research Prize and the Klitzberg Oncology Award.

• Specializes in chronic lymphocytic leukemia and aplastic anemia
• Member of both the Israeli and American Hematology Associations
• Extensive research published in the field of hematology
• Trained at top medical institutions in Israel

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Spielberg is a dedicated oncohematologist at Assuta Medical Center, specializing in blood disorders like aplastic anemia.

• He focuses on both diagnosis and comprehensive treatment planning
• Expert in managing bone marrow failure syndromes
• Works at Israel's largest private hospital, Assuta Medical Center
• Provides personalized care for complex hematological conditions

Dr. Irina Zaidman specializes in pediatric bone marrow transplantation – a critical treatment for aplastic anemia – at Hadassah Medical Center.

• Fellowship in pediatric BMT at Hospital for Sick Children in Toronto
• Board member of Israeli Pediatric Hemato-Oncology Society
• Member of European and American BMT societies
• Published research on pediatric bone marrow transplants

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Performed over 3,500 bone marrow transplants – recognized by Forbes as one of the best doctors in 2018.

• 28 years of experience of experience in pediatric hematology
• Specializes in treating children with rare blood disorders
• Known among patients as 'the one who transplants life'
• Works at Hadassah Medical Center

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.